glp-1 news today november 5 2025 As Drugs Go Mainstream, This Expert Says Health is More than a Number on a Scale Mapping the effectiveness and risks

This change would affect approximately 3.4 million Medicare and 4 million Medicaid beneficiaries

Jimena Hathaway, MD, MPH, indicates that the use of Wegovy increases the risk of a certain type of blindness and vision loss

Currently, Medicare coverage for these drugs is limited to treating diabetes under existing rules, leaving those seeking coverage for weight loss without widespread support

According to the brand's published website, it's designed to "support the behavior side of GLP-1 use" - the protein targets, the resistance-training habits, the consistency tracking that your clinical visit every few weeks simply can't monitor in real time